Showing results (641-650 of 737) with videos related to

Sort By:
Pageof 74
AJNR. American Journal of Neuroradiology|June 20, 2020
Cerebral Venous Thrombosis Associated with COVID-19D D Cavalcanti, E Raz, M Shapiro, et al.
Current Problems in Cardiology|February 5, 2023
Heart Failure With Stable Mildly-reduced Ejection Fraction: Prognosis and Predictors of OutcomesMohamad K Soufi, Mohamed F Almahmoud, Amer N Kadri, et al.
International Journal of Toxicology|June 20, 2024
Safety Assessment of a Novel Intravenous Diclofenac Sodium Formulation Following 28-Day Repeated Administration in Wistar RatsLaxit K Bhatt, Chitrang R Shah, Jitendra H Patel, et al.
British Journal of Pharmacology|April 29, 2017
ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitusMukul R Jain, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Virus Genes|October 19, 2010
Emergence of amantadine-resistant avian influenza H5N1 virus in IndiaC Tosh, H V Murugkar, S Nagarajan, et al.
World Journal of Diabetes|July 11, 2018
Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitusVishal J Patel, Amit A Joharapurkar, Samadhan G Kshirsagar, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 19, 2026
Association of CFRD development among females with CF who use hormonal contraceptionF N Khan, A Magaret, C Hsu, et al.
Toxicology and Applied Pharmacology|January 24, 2024
HIF-PHD inhibitor desidustat ameliorates iron deficiency anemiaVishal J Patel, Amit Joharapurkar, Samadhan G Kshirsagar, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 28, 2013
Too Fit To Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fractureL M Giangregorio, A Papaioannou, N J Macintyre, et al.
British Journal of Cancer|January 31, 2013
A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinomaM Peeters, A H Strickland, M Lichinitser, et al.
Pageof 74